Showing results (471-480 of 846) with videos related to
Sort By:
Pageof 85
Alzheimer'S Research & Therapy|November 29, 2022
Gantenerumab: an anti-amyloid monoclonal antibody with potential disease-modifying effects in early Alzheimer's diseaseRandall J Bateman, Jeffrey Cummings, Scott Schobel, et al.Journal of Translational Medicine|November 2, 2012
Alzheimer's disease biomarker discovery using in silico literature mining and clinical validationInes Greco, Nicola Day, Joanna Riddoch-Contreras, et al.The New England Journal of Medicine|January 24, 2014
Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's diseaseRachelle S Doody, Ronald G Thomas, Martin Farlow, et al.Alzheimer'S Research & Therapy|June 12, 2015
Peripheral and central effects of γ-secretase inhibition by semagacestat in Alzheimer's diseaseRachelle S Doody, Rema Raman, Reisa A Sperling, et al.Alzheimer'S Research & Therapy|August 8, 2019
Further analyses of the safety of verubecestat in the phase 3 EPOCH trial of mild-to-moderate Alzheimer's diseaseMichael F Egan, Yuki Mukai, Tiffini Voss, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 26, 2011
AMPA workshop on challenges faced by investigators conducting Alzheimer's disease clinical trialsBruno Vellas, Alain Pesce, Philippe H Robert, et al.Neurobiology of Aging|December 24, 2011
Tocopherols and tocotrienols plasma levels are associated with cognitive impairmentFrancesca Mangialasche, Weili Xu, Miia Kivipelto, et al.Cerebral Cortex (New York, N.Y. : 1991)|May 15, 2016
Disrupted Network Topology in Patients with Stable and Progressive Mild Cognitive Impairment and Alzheimer's DiseaseJoana B Pereira, Mite Mijalkov, Ehsan Kakaei, et al.Journal of the Neurological Sciences|July 24, 2012
Methodological challenges in designing dementia prevention trials - the European Dementia Prevention Initiative (EDPI)Edo Richard, Sandrine Andrieu, Alina Solomon, et al.Geroscience|July 19, 2024
Body composition and aging: cross-sectional results from the INSPIRE study in people 20 to 93 years oldMarguerite Briand, Jeremy Raffin, Emmanuel Gonzalez-Bautista, et al.Pageof 85